2,490 Shares in Astera Labs, Inc. $ALAB Acquired by Encompass More Asset Management

Encompass More Asset Management purchased a new position in Astera Labs, Inc. (NASDAQ:ALAB) during the 3rd quarter, HoldingsChannel.com reports. The firm purchased 2,490 shares of the company’s stock, valued at approximately $886,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of ALAB. BlackRock Inc. bought a new position in shares of Astera Labs in the second quarter worth about $6,609,581,000. Bank of America Corp DE purchased a new position in Astera Labs in the 2nd quarter worth about $1,061,791,000. Atreides Management LP lifted its holdings in Astera Labs by 108.9% during the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after buying an additional 1,754,593 shares in the last quarter. Amundi lifted its holdings in Astera Labs by 77.9% during the 1st quarter. Amundi now owns 1,880,830 shares of the company’s stock valued at $206,139,000 after buying an additional 823,477 shares in the last quarter. Finally, Deutsche Bank AG bought a new stake in Astera Labs during the 2nd quarter valued at about $325,602,000. 60.47% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

ALAB has been the subject of several research reports. Morgan Stanley boosted their price objective on shares of Astera Labs to $335.00 and gave the company an “overweight” rating in a research report on Monday, August 3rd. UBS Group reaffirmed a “neutral” rating and set a $425.00 target price on shares of Astera Labs in a research report on Wednesday, August 5th. Northland Securities lowered shares of Astera Labs from an “outperform” rating to a “market perform” rating in a research report on Friday, October 9th. Susquehanna lifted their price target on shares of Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a research note on Friday, July 31st. Finally, Needham & Company LLC boosted their price target on Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. Eleven research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $348.33.

Insider Transactions at Astera Labs

In related news, CEO Jitendra Mohan sold 90,630 shares of the company’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the sale, the chief executive officer directly owned 1,266,665 shares in the company, valued at $431,109,432.75. This represents a 6.68% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Manuel Alba sold 183,000 shares of the company’s stock in a transaction on Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total value of $51,263,790.00. Following the sale, the director owned 253,863 shares of the company’s stock, valued at $71,114,642.19. This trade represents a 41.89% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 408,558 shares of company stock worth $127,306,034. Company insiders own 10.40% of the company’s stock.

Astera Labs Stock Down 5.4%

Shares of NASDAQ:ALAB opened at $285.82 on Friday. The firm has a 50 day moving average of $314.86 and a 200 day moving average of $297.01. The company has a market capitalization of $49.59 billion, a price-to-earnings ratio of 141.50 and a beta of 3.68. Astera Labs, Inc. has a 52 week low of $97.89 and a 52 week high of $499.48.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%. The business had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. During the same quarter last year, the firm earned $0.44 EPS. The business’s revenue for the quarter was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, sell-side analysts expect that Astera Labs, Inc. will post 2.70 EPS for the current year.

Astera Labs Profile

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.